| 000 | 01628 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516090930.0 | ||
| 264 | 0 | _c20120814 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1550-6606 | ||
| 024 | 7 |
_a10.4049/jimmunol.1103176 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMizutani, Nobuaki | |
| 245 | 0 | 0 |
_aComplement C3a-induced IL-17 plays a critical role in an IgE-mediated late-phase asthmatic response and airway hyperresponsiveness via neutrophilic inflammation in mice. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cJun 2012 |
||
| 300 |
_a5694-705 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xphysiology |
| 650 | 0 | 4 |
_aAsthma _ximmunology |
| 650 | 0 | 4 |
_aBronchial Hyperreactivity _ximmunology |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aComplement C3a _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aImmunoglobulin E _xphysiology |
| 650 | 0 | 4 |
_aInflammation Mediators _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aInterleukin-17 _xbiosynthesis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNeutrophils _ximmunology |
| 650 | 0 | 4 |
_aReceptors, Complement _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aGoshima, Hirofumi | |
| 700 | 1 | _aNabe, Takeshi | |
| 700 | 1 | _aYoshino, Shin | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 188 _gno. 11 _gp. 5694-705 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4049/jimmunol.1103176 _zAvailable from publisher's website |
| 999 |
_c21737477 _d21737477 |
||